We are live on ! Find out more
SRC

Shufro Rose & Co Portfolio holdings

AUM $1.74B
1-Year Est. Return 34.09%
This Fund
S&P 500
This Quarter Est. Return
-4.54%
1 Year Est. Return
+34.09%
3 Year Est. Return
+68.11%
5 Year Est. Return
+74.85%
10 Year Est. Return
+251.8%
AUM
$1B
AUM Growth
-$153M
Cap. Flow
-$97.3M
Cap. Flow %
-9.72%
Top 10 Hldgs %
38.56%
Holding
347
New
24
Increased
109
Reduced
88
Closed
13

Sector Composition

Rank Sector Weight
1 Miscellaneous 37.87%
2 Technology 19.35%
3 Financials 9.93%
4 Healthcare 9.86%
5 Consumer Discretionary 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ED icon
201
Consolidated Edison
ED
$39.4B
$349K 0.03%
4,067
+10
+0.2% +$965
GE icon
202
GE Aerospace
GE
$329B
$349K 0.03%
9,045
IJH icon
203
iShares Core S&P Mid-Cap ETF
IJH
$122B
$346K 0.03%
7,885
-150
-2% -$7.25K
IMTM icon
204
iShares MSCI Intl Momentum Factor ETF
IMTM
$4.3B
$346K 0.03%
12,891
+4,532
+54% +$134K
AGG icon
205
iShares Core US Aggregate Bond ETF
AGG
$137B
$342K 0.03%
3,546
+167
+5% +$16.9K
EXPE icon
206
Expedia Group
EXPE
$34B
$342K 0.03%
+3,645
New +$372K
VSS icon
207
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.9B
$334K 0.03%
3,601
+1,256
+54% +$131K
BSCQ icon
208
Invesco BulletShares 2026 Corporate Bond ETF
BSCQ
$3.36B
$328K 0.03%
17,580
-5,909
-25% -$114K
NOC icon
209
Northrop Grumman
NOC
$75.3B
$325K 0.03%
+690
New +$329K
REFR icon
210
Research Frontiers
REFR
$12.9M
$325K 0.03%
152,750
-3,231
-2% -$6.6K
CSX icon
211
CSX Corp
CSX
$88.5B
$324K 0.03%
12,146
VGM icon
212
Invesco Trust Investment Grade Municipals
VGM
$522M
$323K 0.03%
34,500
-500
-1% -$5.23K
VMI icon
213
Valmont Industries
VMI
$9.28B
$322K 0.03%
1,200
MPT
214
Medical Properties Trust
MPT
$2.18B
$321K 0.03%
27,100
+2,000
+8% +$30.3K
FRD icon
215
Friedman Industries
FRD
$304M
$320K 0.03%
45,000
-29,331
-39% -$262K
LHX icon
216
L3Harris
LHX
$46.6B
$316K 0.03%
1,520
CNNE icon
217
Cannae Holdings
CNNE
$661M
$310K 0.03%
15,000
NVS icon
218
Novartis
NVS
$268B
$310K 0.03%
4,080
+40
+1% +$3.32K
ABT icon
219
Abbott
ABT
$175B
$308K 0.03%
3,182
-38
-1% -$4.05K
PFL
220
PIMCO Income Strategy Fund
PFL
$358M
$308K 0.03%
38,600
IHI icon
221
iShares US Medical Devices ETF
IHI
$3.25B
$307K 0.03%
+6,500
New +$337K
REGN icon
222
Regeneron Pharmaceuticals
REGN
$80.2B
$305K 0.03%
443
ONT
223
Onterris Inc
ONT
$616M
$304K 0.03%
9,031
ESGV icon
224
Vanguard ESG US Stock ETF
ESGV
$13.4B
$302K 0.03%
4,800
BA icon
225
Boeing
BA
$158B
$301K 0.03%
2,490

Similar funds

Shufro Rose & Co's Q3 2022 Portfolio in Review

As of Q3 2022, Shufro Rose & Co held 347 positions worth $1B, down 13% from $1.15B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Shufro Rose & Co withdrew a net $97.3M in Q3 2022, closing 13 positions and reducing 88 holdings. Its most notable exit was Alleghany Corp, an estimated $8.81M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 38% of assets, down from 42% a quarter earlier, followed by Technology and Financials.

Against the trend, Shufro Rose & Co opened a new position in Neogen worth $351K.

  • Shufro Rose & Co's largest Q3 2022 buy was Neogen: 25,136 shares worth $351K.
  • Shufro Rose & Co added most to iShares iBonds Dec 2026 Term Corporate ETF in Q3 2022, an estimated $26.5M increase.
  • Shufro Rose & Co's biggest Q3 2022 reduction was JPMorgan Ultra-Short Income ETF, cutting an estimated $58.8M.
  • Shufro Rose & Co fully exited Alleghany Corp in Q3 2022, selling an estimated $8.81M.
  • Shufro Rose & Co's ten largest holdings make up 39% of its $1B portfolio in Q3 2022.
  • Shufro Rose & Co opened 24 new positions and closed 13 in Q3 2022.
  • Shufro Rose & Co's portfolio value fell 13% quarter-over-quarter to $1B.

Based on Shufro Rose & Co's 13F filing for Q3 2022, filed 24 Oct 2022.